Schedule 13G ownership disclosure

ALAUNOS THERAPEUTICS INC

Common Stock, $0.001 par value per share · CUSIP: 98973P309

Event date: 2025-10-14

Filing-level shares
0.00
Percent of class
0%
  • Strategic EP, LLC

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-099624
Form type
SCHEDULE 13G/A
Filer
Alaunos Therapeutics, Inc.
CIK
CIK 1107421
Filed
Oct 16, 2025
Reporting period
Oct 14, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub